About Avicanna

Avicanna has rooted itself as an
innovative biopharmaceutical company
in the medical cannabis space.

Research and Development (R&D)

All R&D is conducted in collaboration with leading Canadian research and medical institutions including the University of Toronto.

20+

scientists operating out of Canada, USA, Colombia and Jamaica

40,000

square foot R&D facility : JLABS @ Toronto Johnson & Johnson

University of Toronto

Exclusive research and collaboration agreement with Dr. Christine Allen’s
Research Group (CARG) in the Leslie Dan Faculty of Pharmacy.
Collaboration includes formulation development, in vitro and in vivo analysis.

Clinical Development Program

Focused on developing evidence-based pharmaceutical level and indication specific products (ANDA/DIN’s)